Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Clonidine hydrochloride

EU orphan designation number: EU/3/11/919   
Active ingredient: Clonidine hydrochloride
Indication: Prevention of oral mucositis in head and neck cancer patients undergoing radiation therapy
Sponsor: Monopar Therapeutics Inc
12 rue Anselme, 93400 Saint-Ouen, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/11/2011 Orphan designation EMA/OD/069/11 (2011)7897 of 27/10/2011
24/10/2014 Change of name and/or address of sponsor
23/10/2017 Transfer of orphan designation EMA/OD/069/11/T/01 (2017)7162 of 19/10/2017